StockIQStockIQ.tech

Maze Therapeutics, Inc. (MAZE) Stock Analysis

--

Free AI-powered analysis and research for Maze Therapeutics, Inc. stock

Sector: Healthcare

Full MAZE report

Maze Therapeutics, Inc. (MAZE) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.

Analyze MAZE Now β†’

πŸ“° Latest Update

Wall Street Analysts Predict a 93.92% Upside in Maze Therapeutics, Inc. (MAZE): Here's What You Should Know

Maze Therapeutics, Inc. (MAZE) has seen a 22% increase in its stock price over the past month, closing at $32.25. Wall Street analysts project a mean price target of $62.54, suggesting a potential upside of 93.9%, with estimates ranging from $46.00 to $110.00. Despite the optimistic outlook, the article cautions investors to approach price targets with skepticism, emphasizing the importance of earnings estimate revisions, which have shown positive trends for MAZE.

Read full article β†’

History

People also watch

MCK
McKesson Corporation
--
CVS
CVS Health Corporation
--
ELV
Elevance Health Inc.
--
ATOS
Atossa Therapeutics, Inc.
--
NVCR
NovoCure Limited
--